|1.||Jin, Peng: 2 articles (01/2013 - 11/2012)|
|2.||Elf, Shannon: 2 articles (01/2013 - 11/2012)|
|3.||Fan, Jun: 2 articles (01/2013 - 11/2012)|
|4.||Xie, Jianxin: 2 articles (01/2013 - 11/2012)|
|5.||Chen, Jing: 2 articles (01/2013 - 11/2012)|
|6.||Khuri, Fadlo R: 2 articles (01/2013 - 11/2012)|
|7.||Shin, Dong M: 2 articles (01/2013 - 11/2012)|
|8.||He, Chuan: 2 articles (01/2013 - 11/2012)|
|9.||Kang, Yibin: 2 articles (01/2013 - 11/2012)|
|10.||Hitosugi, Taro: 2 articles (01/2013 - 11/2012)|
04/01/1991 - "Glycolytic pathway of the human malaria parasite Plasmodium falciparum: primary sequence analysis of the gene encoding 3-phosphoglycerate kinase and chromosomal mapping studies."
04/01/1991 - "We have isolated and characterised the gene (PGK) encoding the glycolytic enzyme 3-phosphoglycerate kinase (PGK) from the human malaria parasite Plasmodium falciparum. "
|2.||Brain Ischemia (Cerebral Ischemia)
12/01/2014 - "Immunohistochemistry studies of brain tissue after cerebral ischemia showed that SRR is expressed in neurons, and 3-phosphoglycerate dehydrogenase (3-PGDH), which synthesizes L-serine from 3-phosphoglycerate, is located in astrocytes, supporting the results of the in vitro experiments. "
01/01/2013 - "Moreover, Y26 phosphorylation of PGAM1 is common in human cancer cells and contributes to regulation of 3-phosphoglycerate and 2-phosphoglycerate levels, promoting cancer cell proliferation and tumour growth. "
11/13/2012 - "We found that the glycolytic enzyme phosphoglycerate mutase 1 (PGAM1), commonly upregulated in human cancers due to loss of TP53, contributes to biosynthesis regulation in part by controlling intracellular levels of its substrate, 3-phosphoglycerate (3-PG), and product, 2-phosphoglycerate (2-PG). "
06/01/1975 - "Glyceraldehyde 3-phosphate dehydrogenase and 3-phosphoglycerate kinase are, together with some other enzymes, present on the surface of intact Ehrlich tumor cells. "
04/01/2004 - "Significant differences were observed in (i) the level of 3-phosphoglycerate (3-PGA) and phosphoenolpyruvate (PEP), metabolites associated with starvation; (ii) the rate of fructose 1,6-bisphosphate (FBP) depletion upon glucose exhaustion; and (iii) the NAD(+)/NADH ratio during glucose catabolism. "
08/01/1972 - "3. After 6 days of starvation the hepatic concentrations of oxaloacetate, citrate, phosphoenolpyruvate, 2-phosphoglycerate, 3-phosphoglycerate, glucose, glycogen, ATP and NAD(+) had all decreased, as had the hepatic activities of phosphopyruvate carboxylase (EC 22.214.171.124) and pyruvate kinase (EC 126.96.36.199). "
10/01/2002 - "Purification and characterization of 3-phosphoglycerate kinase from Ehrlich ascites carcinoma cells."
10/01/2002 - "3-Phosphoglycerate kinase (3-PGK) has been purified to apparent homogeneity from Ehrlich ascites carcinoma (EAC) cells by (NH4)2SO4 precipitation, gel filtration and ion-exchange chromatography. "
07/01/1985 - "From experiments with both cultured mouse carcinoma FM3A cells and isolated enzymes, it was shown that koningic acid is a specific inhibitor of glyceraldehyde 3-phosphate dehydrogenase that catalyzes the conversion of glyceraldehyde 3-phosphate to 3-phosphoglycerate."
|2.||Phosphoglycerate Dehydrogenase (Dehydrogenase, Phosphoglycerate)
|4.||2-phosphoglycerate (glycerate 2-phosphate)
|8.||Glyceraldehyde 3-Phosphate (Glyceraldehyde 3 Phosphate)
|1.||Homologous Transplantation (Allograft)